Professional Documents
Culture Documents
objectives
• Define neoplasia
• Describe the NOMENCLATURE of benign
and malignant neoplasms
• Discuss the biology of tumor growth
• Define dysplasia and describe its
pathological features
NEOPLASIA
• Why is it important to study of neoplasia?
Determines consistency
The mass was excised and displayed for you in the Rt photo. It was bony hard in
consistency. Describe the excised mass?
This is another example of the
same tumor, but excised from a rib.
In what way it differs from the
previous lesion*?
whole-mount appearance of the lesion on the Lt and HP view of the
surface on the Rt. Describe. What you call this lesion?
Chondroma
This is a benign tumor of the thyroid gland. It is surrounded by a thin white capsule.
This is a microscopic section from a similar mass. Describe
This is a section from another but similar lesion. Describe.
A 15-year-old boy had almost 50 resections of multiple laryngeal, tracheal and
bronchial lesions, beginning at seven years of age, and finally he died of
suffocation. Below are post-mortem specimens of the larynx & trachea displaying
the multiple abnormalities. Describe.
Below is a histological section of one of the lesions,
describe.
These are masses excised from the ovary (A & B), describe each.
How you name this neoplasm?
B
This is a microscopic section from one of the warty projections seen
in the gross specimen B. Describe
This is a part of the large intestine displaying multiple abnormalities, describe?
Below is a histological section from one of the polyps. Describe.
NOMENCLATURE OF BENIGN TUMORS
• By attaching suffix -oma to cell of origin
• Tumors of mesenchymal cells follow this rule
-fibroma -chondroma -osteoma
(A) metaplasia.
(B) dysplasia.
(C) anaplasia.
(U) hyperplasia.
(E) desmoplasia.
.1Reversible disorderly maturation with
variability in size, shape, and polarity of cells is:
(A) metaplasia.
(B) dysplasia.
(C) anaplasia.
(U) hyperplasia.
(E) desmoplasia.
A 70-year-old
female has had
for decades
slowly but
progressively
enlarging a mass
in the Rt parotid
area. What do
you think the
most-likely
possibility?
This is an identical
but smaller mass
removed together
with the related
parotid gland.
Describe
This is a histological section from the same tumor, describe.
Another area from the same tumor, what does it show?
NOMENCLATURE OF MALIGNANT TUMORS
• Follows essentially same scheme used for benign neoplasms
+certain additions
• Sarcomas (Greek sar = fleshy:)
-malignant tumors arising from or differentiating towarsd
mesenchymal cells
- generally scant CT stroma fleshy consistency
• Nomenclature of sarcomas relies on either
a. cell of origin
b. differentiation
- fibrosarcoma (fibroblasts)
- liposarcoma (lipocytes)
- leiomyosarcoma (SMCs)
- rhabdomyosarcoma (striated muscle cells)
• Carcinoma: malignant neoplasm of epithelial cell origin derived from
any one of three germ layers
- arising in epidermal epithelial cells (ectoderm)
- derived from renal tubules (mesoderm)
- originating from epithelial cells line GIT (endoderm)
• Further qualified according to morphology e.g.
- with a glandular growth pattern: adenoca
- with squamous cells arising in any epithelium: squamous cell ca.
• Specify organ of origin e.g.
- Renal cell Ca.
- Bronchogenic squamous cell Ca.
Undifferentiated malignant tumor c/o undifferentiated cells (no
enough criteria to point to site of origin or differentiation
Squamous nests
glands/strands/sheets
scattered within Cartilage/bone
myxoid stroma
Melanoma (melanocarcinoma)
(A) Carcinoma.
(B) Choristoma.
(C) Hamartoma.
(D) Sarcoma.
(E) Teratoma.
.3Which of the following terms refers to a
malignant tumor of mesenchymal tissue?
(A) Carcinoma.
(B) Choristoma.
(C) Hamartoma.
(D) Sarcoma.
(E) Teratoma.
The microscopic appearance of a
neoplasm from a 58-year-old female is
shown in the figure. This neoplasm is
best described as a(an:)
(A)Adenoma.
(B)Well-differentiated
adenocarcinoma.
(A)Adenoma.
(B)Well-differentiated
adenocarcinoma.
I. Malignant transformation
Normal
adenoma
carcinoma
Poorly differentiated carcinoma
neoplastic.
More important as a morphologic feature of malignancy is the
presence of atypical mitotic figures:
Tripolar, quadripolar, or multipolar mitoses (instead of the
normal bipolar spindles)
.4Loss of polarity:
This means disturbed orientation of the cells.
In malignancy, sheets of tumor cells grow in disorganized
fashion.
5. Other changes:
a. Formation of tumor giant cells.
Some of these abnormally large cells possess only a single huge
pleomorphic nucleus; others have two or more nuclei.
b. Foci of ischemic necrosis.
Undifferentiated/Anaplastic Carcinoma
This neoplasm is so poorly differentiated that it is difficult to tell the cell of origin. Note that nucleoli
are numerous and large in this neoplasm. Neoplasms with no differentiation are designated anaplastic.
Abnormal Mitoses
Here are three abnormal mitoses. Mitoses by themselves are not indicators of malignancy. However,
abnormal mitoses are highly indicative of malignancy. The marked pleomorphism and
hyperchromatism of surrounding cells also favors malignancy.
Rhabdomyosarcoma
Pleomorphic rhabdomyosarcoma
showing prominent pleomorphism,
frankly malignant nuclei &
malignant multinucleated giant
cells.
Foci of ischemic necrosis
.4A biopsy of the stomach reveals an area of
normal-appearing pancreatic tissue. This is an
example of which of the following lesions?
(A) Adenoma.
(B) Choristoma.
(C) Hamartoma.
(D) Metastatic carcinoma.
(E) Teratoma.
4. A biopsy of the stomach reveals an area of
normal-appearing pancreatic tissue. This is an
example of which of the following lesions?
(A) Adenoma.
(B) Choristoma.
(C) Hamartoma.
(D) Metastatic carcinoma.
(E) Teratoma.
Dysplasia
This is a section from a laryngeal biopsy of a heavy smoker. What
type of epithelium is this? How does it differ from normal? Describe.
This is a similar lesion showing more severe changes. What is your
diagnosis?
Cervix uteri severe dysplasia amounting to carcinoma in situ
DYSPLASIA
• “disordered growth”.
• encountered principally in epithelia
• characterized by
1. Pleomorphism
2. Loss of polarity
3. Nuclear Changes
a. hyperchromasia
b. ↑N/C
c. ↑Mitotic figures:
- Almost invariably normal
- Frequently appear in abnormal locations
• Mild/moderate/severe CIS invasion
• Dysplastic changes often found adjacent to foci of invasive ca
II. GROWTH RATE OF THE TRANSFORMED CELLS
The growth rate of neoplasms (i.e. how rapidly they increase
in size) influences:
●Their clinical outcome.
●Their response to therapy.
Neoplasms are now considered clonal i.e. originating from one
(or at most few) initially transformed cells (I-TC.)
For the tumor to be clinically detectable (at least 1 g in wt), the
I-TC and its progeny (collectively referred to as tumor cell
population) must undergo at least 30 population doublings.
80cbMngl
l
......clnl__,
1 g m -1 0 'C I I I
d i . C IIIIII _ ,
10cbMngl
l
..........
111g-101'CIII
M I D dm u m
.......... . ....
PIIJ • Dj'
The growth rate of a tumor is determined by three main
factors:
1.The doubling time of tumor cells (length of the cell cycle.)
2.The size of. (Replicative pool refers to that part of the tumor
made up of exclusively of dividing cells.)
3. The rate at which cells leave the growing tumor.
As tumors continue to grow, cells leave the replicative pool
in ever-increasing numbers due to:
1. Shedding.
2. Necrosis due to lack of nutrients.
3. Apoptosis.
4. Differentiation.
5. Reversion to G.0
Schematic representation of tumor growth
Practical lessons deduced from studies of tumor cell kinetics